PEPTIDE FOR TREATING CYTOKINE STORM SYNDROME Russian patent published in 2025 - IPC A61K38/17 A61P31/12 A61P37/00 

FIELD: biotechnology.

SUBSTANCE: invention relates to biotechnology, in particular to a pharmaceutical composition containing an APL type peptide identified as SEQ ID NO: 1, as an inhibitor of a hyperinflammation state, characterized by an increase in the levels of cytokines or interleukins and inflammation molecules, which increase their concentration to achieve a condition defined as a "cytokine storm". Concentrations of sucrose in said composition increase the biological activity of the peptide, facilitating its intravenous application.

EFFECT: said peptide in a pharmaceutical composition is useful for preparing a medicament for treating diseases associated with hyperinflammation, such as Covid-19, dengue fever, macrophage activation syndrome, respiratory sepsis, and with chimeric antigen receptor T-cell therapies, as well as acute respiratory distress syndrome.

11 cl, 2 dwg, 4 tbl, 9 ex